Form 4 for TECH Bio-Techne
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-05 · accession 0001062993-23-016036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-08 | 2023-08-05 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +8,060 | 23.3K | +53% | $0 |
| D | 2023-08-08 | 2023-08-05 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $82.17 | -4,139 | 19.1K | -18% | -$340.1K |
| D | 2023-08-08 | 2023-08-05 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | -8,060 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-05 | M | A | 8,060 | $0.00 | 23,264 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-05 | F | D | 4,139 | $82.17 | 19,125 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-08-05 | M | D | 8,060 | $0.00 | 0 | D | — · — to — | 8,060 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) On 8/5/2023, the Board of Directors certified vesting of 8,060 performance RSUs. |